Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Musculoskeletal

Bone Diseases Clinical Trials

A listing of Bone Diseases medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 Last 

Arizona

Research Site
Tucson Arizona 85704

A clinical research study of Denosumab and Zoledronic acid

Arkansas

Research Site
Fayetteville Arkansas 72703

A clinical research study of Denosumab and Zoledronic acid

California

Research Site
Anaheim California 92801

A clinical research study of Denosumab and Zoledronic acid

Research Site
Campbell California 95008

A clinical research study of Denosumab and Zoledronic acid

Research Site
Fresno California 93720

A clinical research study of Denosumab and Zoledronic acid

Research Site
Pleasant Hill California 94523

A clinical research study of Denosumab and Zoledronic acid

Research Site
Santa Barbara California 93105

A clinical research study of Denosumab and Zoledronic acid

Colorado

The Urology Center of Colorado
Denver Colorado 80211

Osteonecrosis of the Jaw (ONJ) Case Registry

District of Columbia

Research Site
Washington District of Columbia 20010

A clinical research study of Denosumab and Zoledronic acid

Florida

Arthritis and Rheumatic Disease Specialities
Aventura Florida 33180

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Center for Arthritis and Rheumatic Diseases
Miami Florida 33173

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Arthritis Center
Palm Harbor Florida 34684

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Sarasota Arthritis Research Center
Sarasota Florida 34239

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Florida Medical Clinic PA
Zephyrhills Florida 33542

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More »

Research Site
Boynton Beach Florida 33426

A clinical research study of Denosumab and Zoledronic acid

Research Site
Jacksonville Florida 32256

A clinical research study of Denosumab and Zoledronic acid

Georgia

Research Site
Savannah Georgia 31405

A clinical research study of Denosumab and Zoledronic acid

Illinois

Deerbrook Medical Associates
Vernon Hills Illinois 60061

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More »

Chicago Illinois 60611

A clinical research study of BMN 111 for the treatment of Achondroplasia

Research Site
Chicago Illinois 60612

A clinical research study of Denosumab and Zoledronic acid

Research Site
Joliet Illinois 60435

A clinical research study of Denosumab and Zoledronic acid

Research Site
Maywood Illinois 60153

A clinical research study of Denosumab and Zoledronic acid

Research Site
Skokie Illinois 60076

A clinical research study of Denosumab and Zoledronic acid

Research Site
Skokie Illinois 60077

A clinical research study of Denosumab and Zoledronic acid

Indiana

Dawes-Fretzin Clinical Research
Indianapolis Indiana 46256

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More »

Research Site
Anderson Indiana 46016

A clinical research study of Denosumab and Zoledronic acid

Research Site
Fort Wayne Indiana 46845

A clinical research study of Denosumab and Zoledronic acid

Research Site
Indianapolis Indiana 46202

A clinical research study of Denosumab and Zoledronic acid

Iowa

Research Site
Ames Iowa 50010

A clinical research study of Denosumab and Zoledronic acid

Research Site
Iowa City Iowa 52242

A clinical research study of Denosumab and Zoledronic acid

Kentucky

Graves Gilbert Clinic
Bowling Green Kentucky 42101

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More »

Research Site
Paducah Kentucky 42003

A clinical research study of Denosumab and Zoledronic acid

Maine

Research Site
Scarborough Maine 04074

A clinical research study of Denosumab and Zoledronic acid

Maryland

Research Site
Baltimore Maryland 21237

A clinical research study of Denosumab and Zoledronic acid

Research Site
Baltimore Maryland 21204

A clinical research study of Denosumab and Zoledronic acid

Research Site
Baltimore Maryland 21229

A clinical research study of Denosumab and Zoledronic acid

Research Site
Bethesda Maryland 20817

A clinical research study of Denosumab and Zoledronic acid

Research Site
Westminster Maryland 21157

A clinical research study of Denosumab and Zoledronic acid

Massachusetts

Research Site
Boston Massachusetts 02215

A clinical research study of Denosumab and Zoledronic acid

Research Site
Boston Massachusetts 02114

A clinical research study of Denosumab and Zoledronic acid

Research Site
Danvers Massachusetts 01923

A clinical research study of Denosumab and Zoledronic acid

Research Site
Fairhaven Massachusetts 02719

A clinical research study of Denosumab and Zoledronic acid

Michigan

Research Site
Lansing Michigan 48910

A clinical research study of Denosumab and Zoledronic acid

Mississippi

Research Site
Jackson Mississippi 39216

A clinical research study of Denosumab and Zoledronic acid

Missouri

Clayton Medical Research
St. Louis Missouri 63117

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More »

Research Site
Springfield Missouri 65807

A clinical research study of Denosumab and Zoledronic acid

Montana

Research Site
Billings Montana 59101

A clinical research study of Denosumab and Zoledronic acid

Nebraska

Research Site
Lincoln Nebraska 68506

A clinical research study of Denosumab and Zoledronic acid

Research Site
Omaha Nebraska 68198

A clinical research study of Denosumab and Zoledronic acid

Nevada

Research Site
North Las Vegas Nevada 89086

A clinical research study of Denosumab and Zoledronic acid

First 1 2 3 4 5 6 Last